These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 11743509)

  • 1. Isolated mental developmental delay in very low birth weight infants: association with prolonged doxapram therapy for apnea.
    Sreenan C; Etches PC; Demianczuk N; Robertson CM
    J Pediatr; 2001 Dec; 139(6):832-7. PubMed ID: 11743509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain hemodynamic effects of doxapram in preterm infants.
    Dani C; Bertini G; Pezzati M; Pratesi S; Filippi L; Tronchin M; Rubaltelli FF
    Biol Neonate; 2006; 89(2):69-74. PubMed ID: 16158005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxapram and developmental delay at 12 months in children born extremely preterm.
    Lando A; Klamer A; Jonsbo F; Weiss J; Greisen G
    Acta Paediatr; 2005 Nov; 94(11):1680-1. PubMed ID: 16303710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial effects of breast milk in the neonatal intensive care unit on the developmental outcome of extremely low birth weight infants at 18 months of age.
    Vohr BR; Poindexter BB; Dusick AM; McKinley LT; Wright LL; Langer JC; Poole WK;
    Pediatrics; 2006 Jul; 118(1):e115-23. PubMed ID: 16818526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher cumulative doses of erythropoietin and developmental outcomes in preterm infants.
    Brown MS; Eichorst D; Lala-Black B; Gonzalez R
    Pediatrics; 2009 Oct; 124(4):e681-7. PubMed ID: 19786428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Grades I-II intraventricular hemorrhage in extremely low birth weight infants: effects on neurodevelopment.
    Patra K; Wilson-Costello D; Taylor HG; Mercuri-Minich N; Hack M
    J Pediatr; 2006 Aug; 149(2):169-73. PubMed ID: 16887428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic QT/RR relationship of cardiac conduction in premature infants treated with low-dose doxapram hydrochloride.
    Miyata M; Hata T; Kato N; Takeuchi M; Mizutani H; Kubota M; Yamazaki T
    J Perinat Med; 2007; 35(4):330-3. PubMed ID: 17614751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Neurodevelopmental Outcome after Doxapram for Apnea of Prematurity.
    Ten Hove CH; Vliegenthart RJ; Te Pas AB; Brouwer E; Rijken M; van Wassenaer-Leemhuis AG; van Kaam AH; Onland W
    Neonatology; 2016; 110(1):21-6. PubMed ID: 26967910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apnea is associated with neurodevelopmental impairment in very low birth weight infants.
    Janvier A; Khairy M; Kokkotis A; Cormier C; Messmer D; Barrington KJ
    J Perinatol; 2004 Dec; 24(12):763-8. PubMed ID: 15329741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurodevelopmental outcomes of extremely low birth weight infants <32 weeks' gestation between 1993 and 1998.
    Vohr BR; Wright LL; Poole WK; McDonald SA
    Pediatrics; 2005 Sep; 116(3):635-43. PubMed ID: 16143580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurodevelopmental outcome and growth at 18 to 22 months' corrected age in extremely low birth weight infants treated with early erythropoietin and iron.
    Ohls RK; Ehrenkranz RA; Das A; Dusick AM; Yolton K; Romano E; Delaney-Black V; Papile LA; Simon NP; Steichen JJ; Lee KG;
    Pediatrics; 2004 Nov; 114(5):1287-91. PubMed ID: 15520109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing apnea and bradycardia of prematurity - implications for neurodevelopment.
    Pillekamp F; Hermann C; Keller T; von Gontard A; Kribs A; Roth B
    Neonatology; 2007; 91(3):155-61. PubMed ID: 17377399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of chorioamnionitis on neurodevelopmental outcome in preterm infants.
    Polam S; Koons A; Anwar M; Shen-Schwarz S; Hegyi T
    Arch Pediatr Adolesc Med; 2005 Nov; 159(11):1032-5. PubMed ID: 16275792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose doxapram for apnea unresponsive to aminophylline in very low birthweight infants.
    Brion LP; Vega-Rich C; Reinersman G; Roth P
    J Perinatol; 1991 Dec; 11(4):359-64. PubMed ID: 1770394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose doxapram therapy for idiopathic apnea of prematurity.
    Yamazaki T; Kajiwara M; Itahashi K; Fujimura M
    Pediatr Int; 2001 Apr; 43(2):124-7. PubMed ID: 11285061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in neurodevelopmental outcomes at 18 to 22 months' corrected age among infants of less than 25 weeks' gestational age born in 1993-1999.
    Hintz SR; Kendrick DE; Vohr BR; Poole WK; Higgins RD;
    Pediatrics; 2005 Jun; 115(6):1645-51. PubMed ID: 15930228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin concentrations and neurodevelopmental outcome in preterm infants.
    Bierer R; Peceny MC; Hartenberger CH; Ohls RK
    Pediatrics; 2006 Sep; 118(3):e635-40. PubMed ID: 16908620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxapram and hypokalaemia in very preterm infants.
    Fischer C; Ferdynus C; Gouyon JB; Semama DS
    Arch Dis Child Fetal Neonatal Ed; 2013 Sep; 98(5):F416-8. PubMed ID: 23448699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive outcome at 2 years of age in Finnish infants with very low birth weight born between 2001 and 2006.
    Munck P; Haataja L; Maunu J; Parkkola R; Rikalainen H; Lapinleimu H; Lehtonen L;
    Acta Paediatr; 2010 Mar; 99(3):359-66. PubMed ID: 19912142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of doxapram on episodes of apnoea, bradycardia and hypoxaemia in preterm infants.
    Poets CF; Darraj S; Bohnhorst B
    Biol Neonate; 1999 Oct; 76(4):207-13. PubMed ID: 10473894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.